Literature DB >> 11792717

A mutation (-49C>T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia.

Pilar Mozas1, Román Galetto, Marta Albajar, Emilio Ros, Miguel Pocoví, José C Rodríguez-Rey.   

Abstract

We have identified a mutation (-49C>T) in the low-density lipoprotein receptor (LDLR) gene in a Spanish familial hypercholesterolemia (FH) patient. The mutation maps within repeat 3 of the LDLR gene promoter. This region binds Sp1 and collaborates with repeat 2 in the regulation of LDLR gene by sterols. To evaluate whether the mutation influenced the activity of the promoter, luciferase reporter plasmids containing 296 bp of the proximal promoter region were constructed. In transient transfection assays in HepG2 cells, the mutation resulted in an 80% reduction of promoter activity. Also, gel-shift assays demonstrated that the mutation severely affects Sp1 binding. However, the mutated promoter still retains the ability to respond to low sterol concentrations. As the analysis of the LDLR gene did not reveal any other changes, we conclude that the -49C>T mutation is the cause of FH in the patient. The analysis of the proband's pedigree indicated that not all the members of the family having the mutation disclose a FH phenotype. These results support the view that factors other than the presence of the mutation are important in the determination of the clinical phenotype in FH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792717

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Nuclear receptor NR5A2 and bone: gene expression and association with bone mineral density.

Authors:  José A Riancho; Yongjun Liu; Jesús Sainz; Miguel A García-Pérez; José M Olmos; Alfonso Bolado-Carrancio; Carmen Valero; Javier Pérez-López; Antonio Cano; Tielin Yang; Carolina Sañudo; Hong-Wen Deng; José C Rodríguez-Rey
Journal:  Eur J Endocrinol       Date:  2011-11-02       Impact factor: 6.664

2.  Modified methylenedioxyphenol analogs lower LDL cholesterol through induction of LDL receptor expression.

Authors:  Zhekang Ying; Rajagopal Desikan; Xiaohua Xu; Andrei Maiseyeu; Cuiqing Liu; Qinghua Sun; Ouiliana Ziouzenkova; Sampath Parthasarathy; Sanjay Rajagopalan
Journal:  J Lipid Res       Date:  2012-02-21       Impact factor: 5.922

Review 3.  Needles in the genetic haystack of lipid disorders: single nucleotide polymorphisms in the microRNA regulome.

Authors:  Praveen Sethupathy
Journal:  J Lipid Res       Date:  2013-03-15       Impact factor: 5.922

4.  New promoter mutations in the low-density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: molecular and functional analysis.

Authors:  H Francová; M Trbusek; P Zapletalová; V Kuhrová
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

5.  Identification of the Functional Variant(s) that Explain the Low-Density Lipoprotein Receptor (LDLR) GWAS SNP rs6511720 Association with Lower LDL-C and Risk of CHD.

Authors:  Roaa Hani Fairoozy; Jon White; Jutta Palmen; Anastasia Z Kalea; Steve E Humphries
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

6.  LDLR rs688 TT Genotype and T Allele Are Associated with Increased Susceptibility to Coronary Artery Disease-A Case-Control Study.

Authors:  Chandan K Jha; Rashid Mir; Naina Khullar; Shaheena Banu; S M S Chahal
Journal:  J Cardiovasc Dev Dis       Date:  2018-05-29

7.  The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.

Authors:  Isabel De Castro-Orós; Miguel Pocoví; Fernando Civeira
Journal:  Appl Clin Genet       Date:  2010-08-05

8.  A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia.

Authors:  Isabel De Castro-Orós; Javier Pérez-López; Rocio Mateo-Gallego; Soraya Rebollar; Marta Ledesma; Montserrat León; Montserrat Cofán; Jose A Casasnovas; Emilio Ros; Jose C Rodríguez-Rey; Fernando Civeira; Miguel Pocoví
Journal:  BMC Med Genomics       Date:  2014-04-07       Impact factor: 3.063

9.  Functional analysis of four LDLR 5'UTR and promoter variants in patients with familial hypercholesterolaemia.

Authors:  Amna Khamis; Jutta Palmen; Nick Lench; Alison Taylor; Ebele Badmus; Sarah Leigh; Steve E Humphries
Journal:  Eur J Hum Genet       Date:  2014-09-24       Impact factor: 4.246

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.